Video
Journals
Specialty Area
Topics
Institute for Value-Based Medicine
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Advertisement
Contact Info
2 Commerce Drive
Cranbury, NJ 08512
© 2026 MJH Life Sciences
AJMC®
All rights reserved.
AJMC®
All rights reserved.
Social Security's Financial Health Worsens
Medicare
The Obama administration reported a significant deterioration in the financial outlook for Social Security on Monday, while stating that the financial condition of was stable but still unsustainable.
The Social Security trust fund will be exhausted in 2033, three years sooner than projected last year, the administration said. And Medicare’s hospital insurance trust fund will be depleted in 2024, the same as last year’s estimate, it said.
Read the full story: http://hcp.lv/I6Fx6b
Source: The New York Times
TrumpRx Launch Brings Savings—and Uncertainty
February 5th 2026First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.
Read More
The Orphan Drug Act in the Modern Drug Pricing Era
February 3rd 2026Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.
Listen
Closing Gaps in Stroke Care Starts With Defining the US Health Care Safety Net
February 5th 2026Clearer definitions, tailored programs and policies, and telestroke care could help close rural stroke care disparities.
Read More
Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD
January 20th 2026David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.
Listen
New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq
February 4th 2026The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.
Read More
Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries
February 4th 2026Increasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.
Read More
TrumpRx Launch Brings Savings—and Uncertainty
February 5th 2026First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, with potential savings in the millions.
Read More
The Orphan Drug Act in the Modern Drug Pricing Era
February 3rd 2026Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.
Listen
Closing Gaps in Stroke Care Starts With Defining the US Health Care Safety Net
February 5th 2026Clearer definitions, tailored programs and policies, and telestroke care could help close rural stroke care disparities.
Read More
Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD
January 20th 2026David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.
Listen
New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq
February 4th 2026The Consolidated Appropriations Act of 2026 features new language that could change the way that pharmacy benefit managers (PBMs) operate in the US.
Read More
Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries
February 4th 2026Increasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.
Read More